ResearcherCentral South UniversityNo recent work listed
Duo Han
Matched on OpenAlex author ID A5108760885. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2022: 2 papers
Papers 2
- The NF-κB/miR-488/ERBB2 axis modulates pancreatic cancer cell malignancy and tumor growth through cell cycle signaling. Co-author DOI 10.1080/15384047.2022.2054257↗
- DSCR9/miR-21-5p axis inhibits pancreatic cancer proliferation and resistance to gemcitabine via BTG2 signaling. Co-author DOI 10.3724/abbs.2022194↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Wenzhe Gao · 2 shared papers, 2022 · strength 0.31
- Paper The NF-κB/miR-488/ERBB2 axis modulates pancreatic cancer cell malignancy and tumor growth through cell cycle signaling. DOI 10.1080/15384047.2022.2054257↗
- Paper DSCR9/miR-21-5p axis inhibits pancreatic cancer proliferation and resistance to gemcitabine via BTG2 signaling. DOI 10.3724/abbs.2022194↗
- Hongwei Zhu · 2 shared papers, 2022 · strength 0.31
- Paper The NF-κB/miR-488/ERBB2 axis modulates pancreatic cancer cell malignancy and tumor growth through cell cycle signaling. DOI 10.1080/15384047.2022.2054257↗
- Paper DSCR9/miR-21-5p axis inhibits pancreatic cancer proliferation and resistance to gemcitabine via BTG2 signaling. DOI 10.3724/abbs.2022194↗
- Xiao Yu · 1 shared paper, 2022 · strength 0.16
- Yunfei Liu · 1 shared paper, 2022 · strength 0.16
- Xiao Yu · 1 shared paper, 2022 · strength 0.15
- Hui Huang · 1 shared paper, 2022 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.